Evangelos Prokakis

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

International journal of cancer

Cell death & disease

Oncogene

Cell death and differentiation

Universitätsmedizin Göttingen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitätsmedizin Göttingen

Germany

MSc :: Translational Cancer Research

Publications

Evangelos Prokakis, Shaishavi Jansari, Angela Boshnakovska, Maria Wiese, Kathrin Kusch, Christof Maria Kramm, Christian Dullin, Peter Rehling, Markus Glatzel, Klaus Pantel, Harriett Wikman, Steven A Johnsen, Julia Gallwas, Florian Wegwitz
RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer. Cell death & disease 14 (9) (2023)
Garyfallia Pantelaiou-Prokaki, Oliver Reinhardt, Nadine S Georges, David J Agorku, Olaf T Hardt, Evangelos Prokakis, Iga K Mieczkowska, Wolfgang Deppert, Florian Wegwitz, Frauke Alves
Basal-like mammary carcinomas stimulate cancer stem cell properties through AXL-signaling to induce chemotherapy resistance. International journal of cancer 152 (9) (2023)
Garyfallia Pantelaiou-Prokaki, Oliver Reinhardt, Nadine S Georges, David J Agorku, Olaf T Hardt, Evangelos Prokakis, Iga K Mieczkowska, Wolfgang Deppert, Florian Wegwitz, Frauke Alves
Basal-like mammary carcinomas stimulate cancer stem cell properties through AXL-signaling to induce chemotherapy resistance. International journal of cancer 152 (9) (2023)
Garyfallia Pantelaiou-Prokaki, Oliver Reinhardt, Nadine S Georges, David J Agorku, Olaf T Hardt, Evangelos Prokakis, Iga K Mieczkowska, Wolfgang Deppert, Florian Wegwitz, Frauke Alves
Basal-like mammary carcinomas stimulate cancer stem cell properties through AXL-signaling to induce chemotherapy resistance. International journal of cancer 152 (9) (2023)
Garyfallia Pantelaiou-Prokaki, Oliver Reinhardt, Nadine S Georges, David J Agorku, Olaf T Hardt, Evangelos Prokakis, Iga K Mieczkowska, Wolfgang Deppert, Florian Wegwitz, Frauke Alves
Basal-like mammary carcinomas stimulate cancer stem cell properties through AXL-signaling to induce chemotherapy resistance. International journal of cancer (2023)
Garyfallia Pantelaiou-Prokaki, Oliver Reinhardt, Nadine S Georges, David J Agorku, Olaf T Hardt, Evangelos Prokakis, Iga K Mieczkowska, Wolfgang Deppert, Florian Wegwitz, Frauke Alves
Basal-like mammary carcinomas stimulate cancer stem cell properties through AXL-signaling to induce chemotherapy resistance. International journal of cancer 152 (9) (2023)
Marcel Werner, Anna Dyas, Iwan Parfentev, Geske E Schmidt, Iga K Mieczkowska, Lukas C Müller-Kirschbaum, Claudia Müller, Stefan Kalkhof, Oliver Reinhardt, Henning Urlaub, Frauke Alves, Julia Gallwas, Evangelos Prokakis, Florian Wegwitz
ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness. Cell death & disease 13 (9) (2022)
Iga K Mieczkowska, Garyfallia Pantelaiou-Prokaki, Evangelos Prokakis, Geske E Schmidt, Lukas C Müller-Kirschbaum, Marcel Werner, Madhobi Sen, Taras Velychko, Katharina Jannasch, Christian Dullin, Joanna Napp, Klaus Pantel, Harriett Wikman, Maria Wiese, Christof M Kramm, Frauke Alves, Florian Wegwitz
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments. Cell death & disease 12 (12) (2021)
Xin Wang, Ana P Kutschat, Moyuru Yamada, Evangelos Prokakis, Patricia Böttcher, Koji Tanaka, Yuichiro Doki, Feda H Hamdan, Steven A Johnsen
Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas. Cell death and differentiation 28 (7) (2021)
Evangelos Prokakis, Anna Dyas, Regina Grün, Sonja Fritzsche, Upasana Bedi, Zahra B Kazerouni, Robyn Laura Kosinsky, Steven A Johnsen, Florian Wegwitz
USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response. Oncogene 40 (23) (2021)
Florian Wegwitz, Evangelos Prokakis, Anastasija Pejkovska, Robyn Laura Kosinsky, Markus Glatzel, Klaus Pantel, Harriett Wikman, Steven A Johnsen
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis. Cell death & disease 11 (10) (2020)

Evangelos Prokakis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Evangelos Prokakis